Lidosen

Lidocaine Hydrochloride, the active ingredient in Lidosen, is a local anesthetic presented as a sterile solution for intramuscular and subcutaneous use. It provides rapid, reversible loss of sensation for minor surgical, diagnostic, and injection‑site pain relief in adult patients.

GNH USA supplies Lidosen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidosen, a lidocaine‑based local anesthetic, works on peripheral nerves to block pain transmission. - Minor surgical procedures: provides localized numbness to facilitate the operation without systemic anesthesia. - Diagnostic interventions: enables painless tissue sampling or imaging studies that require brief anesthesia. - Injection‑site pain relief: reduces discomfort from subcutaneous or intramuscular injections in various clinical settings.

Lidosen may cause a range of adverse reactions following administration.

Common Side Effects: - Burning or stinging at the injection site - Tingling or numbness extending beyond the intended area - Mild swelling or erythema at the injection site - Dizziness or light‑headedness - Nausea or mild gastrointestinal upset

Serious or Rare Side Effects: - Systemic toxicity manifesting as seizures or CNS depression - Cardiac arrhythmias, including ventricular fibrillation - Severe allergic reactions such as anaphylaxis - Methemoglobinemia leading to cyanosis - Respiratory depression requiring airway support

When using Lidosen, clinicians should observe several safety measures. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Dose minimization: use the lowest effective amount for the intended procedure. - Cardiac monitoring: observe patients for signs of arrhythmia, especially with high doses. - Avoid intravascular injection: aspirate before administration to prevent systemic exposure. - Hepatic impairment: adjust use cautiously in patients with significant liver disease. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture and light.

Lidosen can interact with other medications, requiring attention to potential additive effects.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increased risk of cardiotoxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise lidocaine plasma levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: potential enhancement of bradycardia. - Loop diuretics: may reduce plasma protein binding, increasing free lidocaine. - General anesthetics (e.g., propofol, inhalational agents): additive central nervous system depression.